Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

IL-6 Inhibitor Shows Promise in Diabetic Macular Edema

IL-6 Inhibitor Shows Promise in Diabetic Macular Edema
ShareXFacebook

(MedPage Today) -- DENVER -- Targeting an inflammatory pathway in diabetic macular edema (DME), in addition to angiogenesis, led to greater improvement in visual acuity and retinal anatomy, a randomized trial showed. Single-agent ranibizumab...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement